Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1100 participants.
Also called NCT06243133
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,100 participants
- Registry
-
NCT06243133
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06243133. Randomized; single masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2026-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
- Acronym
- PATH-ICAS
- Condition
- Ischemic Stroke
- Condition
- Intracranial Arteriosclerosis
- Condition
- Secondary Prevention
- Condition
- Antiplatelet Drug
- Intervention (Drug)
- clopidogrel for 90 days combined with aspirin for 90 days
- Intervention (Drug)
- clopidogrel for 30 days combined with aspirin for 90 days
- Lead sponsor
- Sichuan Provincial People's Hospital
Record details
- Record id
cardio:ct-nct06243133- Content hash
d780ac7955c7e501c91526103df18200617a7557cf060516331dc8eb2a91461b